Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
Follow us @OWHealthEditor
RT @OliverWyman : From The #OWRisk Journal: If companies and #hospitals tie their futures to a strategy based on a single potential #COVID19 …
RT @healthpodnet : Check out the latest episode from @OWHealthEditor : Leading from the Front Lines: Advice from a Three-Star General with Ge…
RT @Livongo : Join @Livongo 's @GlenTullman and @OliverWyman 's @SamOnHealth on Friday, June 5, as they discuss and debate how #COVID19 has cr…
RT @MATTERhealth : Last month, @GlenTullman , founder and executive chairman of @Livongo , joined us at a member-exclusive webinar to share hi…
RT @CarenetHealth : For the next 24 months, telehealth will remain the safest means of receiving medical care for many. More predictions her…
RT @BRINKNewsNow : Women make up 65% of #healthcare workers but only 13% of CEOs. What is holding back progress in this industry? https://t.…
New on #OWHealth : Market dynamics are ripe for #mergers and #acquisitions activity. But before being enticed by a mirage, leaders must revisit old lessons > https://t.co/p5i4D0M1qn
RT @OliverWyman : #OWInTheNews @FT : As companies around the world think about bringing their employees #backtotheoffice after #COVID19 , #OWH…
RT @Softheon : Friendly Reminder: TODAY @ 2PM EST join @KJD_31 from @Softheon and Howard Lapsley from @OliverWyman for the webinar, Navigati…
RT @craigstrong : Successful health systems will holistically examine their cost structure, develop an operational blueprint, and establish…
